Completed Access to Information Requests


  • RSS
  • Cite

Transitional Period

Federal departments are moving their web content to As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type




Found 2768 record(s)

Req # A-2019-000797

Adverse Reaction Report (AER). Report number: E2B_02273302.

Organization: Health Canada

15 page(s)
October 2019

Req # A-2019-000798

Adverse Reaction Report (AER). Report number: E2B_02320928.

Organization: Health Canada

13 page(s)
October 2019

Req # A-2013-000123

All records associated with the commitment by Health Canada that Shire BioChem Inc. provide safety information to Health Canada on a regular basis, after an investigation into deaths related to the drug Adderall XR.

Organization: Health Canada

98 page(s)
October 2019

Req # A-2014-000280

All records within Health Canada that contain any of the words or subject matter, including but not limited to: "DUKORAL®, "DUKORAL, "DUKORAL, "Dukoral®, "Dukoral, "Dukoral, "Cholera vaccine, "Vibrio cholera vaccine

Organization: Health Canada

436 page(s)
October 2019

Req # A-2015-000569

All documents and communications concerning contract # 4600001119, which includes all bid submissions, evaluation for all bids, all resulting contracts issued and all communication between buyer and bidder.

Organization: Health Canada

99 page(s)
October 2019

Req # A-2016-000206

Request for the Lot number of Topamax used in Apotex's bioequivalence study and Health Canada review reports for the Apotex Abbreviated New Drug Submission (ANDS) for Apo-Topiramate.

Organization: Health Canada

154 page(s)
October 2019

Req # A-2016-000248

All research documents published or unpublished about human bacteriophage therapy from January 1, 2011 to May 24, 2016

Organization: Health Canada

63 page(s)
October 2019

Req # A-2016-000365

Complaint form 0317 Reference number: 2016-009560- 15 February. Complaint about a product sold to veterinarians under the name “Altervitam 2.2%”. For reference, the drug REGU-MATE DIN# 00641987 is the original product sold by Intervet Canada Corp.

Organization: Health Canada

10 page(s)
October 2019

Req # A-2016-000430

Final versions of all documents about big data or data analytics projects (specifically related to big data or social media data) or pilot projects operating within or for Health Canada produced between Jan. 2014 and June 2016.

Organization: Health Canada

730 page(s)
October 2019

Req # A-2016-001300

All notifiable changes relating to Dominion Pharmacal’s Dom-Tadalafil products, Drug Identification Number (DINs) 02437902, 02437910, 02437929 and 02437937

Organization: Health Canada

140 page(s)
October 2019

What's new in open government?